Citations (103)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
James H. Tabibian & Todd H. Baron. (2018) Endoscopic management of primary sclerosing cholangitis. Expert Review of Gastroenterology & Hepatology 12:7, pages 693-703.
Read now
Read now
Ken Liu, Simone I. Strasser, David J. Koorey, Rupert W. Leong, Michael Solomon & Geoffrey W. McCaughan. (2017) Interactions between primary sclerosing cholangitis and inflammatory bowel disease: implications in the adult liver transplant setting. Expert Review of Gastroenterology & Hepatology 11:10, pages 949-960.
Read now
Read now
Marcus S Noel & Aram F Hezel. (2013) New and emerging treatment options for biliary tract cancer. OncoTargets and Therapy 6, pages 1545-1552.
Read now
Read now
Amit Singal, Theodore H Welling & Jorge A Marrero. (2009) Role of liver transplantation in the treatment of cholangiocarcinoma. Expert Review of Anticancer Therapy 9:4, pages 491-502.
Read now
Read now
Articles from other publishers (99)
Takahiro Miyazu, Natsuki Ishida, Yusuke Asai, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Satoshi Baba & Ken Sugimoto. (2023) Intrahepatic cholangiocarcinoma in patients with primary sclerosing cholangitis and ulcerative colitis: Two case reports. World Journal of Gastrointestinal Surgery 15:6, pages 1224-1231.
Crossref
Crossref
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim & Sang Hyoung Park. (2023) Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study. Intestinal Research 21:2, pages 252-265.
Crossref
Crossref
Maryam Ebadi, Elora Rider, Catherine Tsai, Sarah Wang, Ellina Lytvyak, Andrew Mason & Aldo J. Montano-Loza. (2023) Prognostic Significance of Severe Vitamin D Deficiency in Patients with Primary Sclerosing Cholangitis. Nutrients 15:3, pages 576.
Crossref
Crossref
Mohamed Attauabi, Mads Damsgaard Wewer, Flemming Bendtsen, Jakob Benedict Seidelin & Johan Burisch. (2022) Inflammatory Bowel Diseases Affect the Phenotype and Disease Course of Coexisting Immune-Mediated Inflammatory Diseases: A Systematic Review With Meta-Analysis. Inflammatory Bowel Diseases 28:11, pages 1756-1765.
Crossref
Crossref
Matthew A. Morgan, Rachita Khot, Karthik M. Sundaram, Daniel R. Ludwig, Rashmi T. Nair, Pardeep K. Mittal, Dhakshina M. Ganeshan & Sudhakar K. Venkatesh. (2022) Primary sclerosing cholangitis: review for radiologists. Abdominal Radiology 48:1, pages 136-150.
Crossref
Crossref
Federica Invernizzi, Marta Cilla, Silvia Trapani, Maria Guarino, Valentina Cossiga, Martina Gambato, Maria Cristina Morelli, Filomena Morisco, Patrizia Burra & Annarosa Floreani. (2022) Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice. Journal of Personalized Medicine 12:6, pages 925.
Crossref
Crossref
Rohit Das, Harkirat Singh & Adam Slivka. 2022. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy
1381
1398
.
Tina Boortalary & David Loren. 2022. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
237
264
.
Cyriel Y. Ponsioen, David N. Assis, Kirsten M. Boberg, Christopher L. Bowlus, Mark Deneau, Douglas Thorburn, Lars Aabakken, Martti Färkkilä, Bret Petersen, Christian Rupp & Stefan G. Hübscher. (2021) Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process. Gastroenterology 161:6, pages 1764-1775.e5.
Crossref
Crossref
Rune Erichsen, Ola Olén, Michael C. Sachs, Lars Pedersen, Jonas Halfvarson, Johan Askling, Anders Ekbom, Jonas F. Ludvigsson & Henrik Toft Sørensen. (2021) Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study. Cancer Epidemiology, Biomarkers & Prevention 30:5, pages 886-894.
Crossref
Crossref
Mark R. Deneau, Cara Mack, Emily R. Perito, Amanda Ricciuto, Pamela L. Valentino, Mansi Amin, Achiya Z. Amir, Madeleine Aumar, Marcus Auth, Annemarie Broderick, Matthew DiGuglielmo, Laura G. Draijer, Eleonora Druve Tavares Fagundes, Wael El‐Matary, Federica Ferrari, Katryn N. Furuya, Nitika Gupta, Jessica T. Hochberg, Matjaz Homan, Simon Horslen, Raffaele Iorio, M. Kyle Jensen, Maureen M. Jonas, Binita M. Kamath, Nanda Kerkar, Kyung Mo Kim, Kaija‐Leena Kolho, Bart G.P. Koot, Trevor J. Laborda, Christine K. Lee, Kathleen M. Loomes, Mercedes Martinez, Alexander Miethke, Tamir Miloh, Douglas Mogul, Saeed Mohammad, Parvathi Mohan, Stacy Moroz, Nadia Ovchinsky, Sirish Palle, Alexandra Papadopoulou, Girish Rao, Alexandre Rodrigues Ferreira, Pushpa Sathya, Kathleen B. Schwarz, Uzma Shah, Eyal Shteyer, Ruchi Singh, Vratislav Smolka, Nisreen Soufi, Atsushi Tanaka, Raghu Varier, Bernadette Vitola, Marek Woynarowski, Melissa Zerofsky, Andréanne Zizzo & Stephen L. Guthery. (2020) The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) Index: A Prognostic Tool for Children. Hepatology 73:3, pages 1074-1087.
Crossref
Crossref
Tina Boortalary & David Loren. 2021. Hepato-Pancreato-Biliary Malignancies. Hepato-Pancreato-Biliary Malignancies
1
28
.
Mark R. Deneau, Pamela L. Valentino, Cara Mack, Khaled Alqoaer, Mansi Amin, Achiya Z. Amir, Madeleine Aumar, Marcus Auth, Annemarie Broderick, Matthew DiGuglielmo, Laura G. Draijer, Wael El-Matary, Federica Ferrari, Katryn N. Furuya, Frederic Gottrand, Nitika Gupta, Matjaz Homan, M.K. Jensen, Binita M. Kamath, Kyung Mo Kim, Kaija-Leena Kolho, Bart Koot, Raffaele Iorio, Mercedes Martinez, Tamir Miloh, Parvathi Mohan, Sirish Palle, Alexandra Papadopoulou, Amanda Ricciuto, Lawrence Saubermann, Pushpa Sathya, Eyal Shteyer, Vratislav Smolka, Atsushi Tanaka, Raghu Varier, Veena Venkat, Bernadette Vitola, Marek WoynarowskiStephen Guthery. (2020) Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. Journal of Pediatric Gastroenterology & Nutrition 70:1, pages e12-e17.
Crossref
Crossref
Rohit Das, Harkirat Singh & Adam Slivka. 2020. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy
1
19
.
N. Golse & E. Vibert. (2019) Chirurgia del colangiocarcinoma intraepatico e peri-ilare. EMC - Tecniche Chirurgiche Addominale 25:1, pages 1-14.
Crossref
Crossref
N. Golse & E. Vibert. (2019) Cirugía del colangiocarcinoma intrahepático y perihiliar. EMC - Técnicas Quirúrgicas - Aparato Digestivo 35:1, pages 1-15.
Crossref
Crossref
Carolin F. Manthey, Marcial Sebode, Helen Hayward-Koennecke, Andreas Lutterotti & Samuel Huber. 2019. Nijkamp and Parnham's Principles of Immunopharmacology. Nijkamp and Parnham's Principles of Immunopharmacology
751
775
.
James H. Tabibian & Christopher L. Bowlus. (2018) WITHDRAWN: Primary sclerosing cholangitis: A review and update. Liver Research.
Crossref
Crossref
James H. Tabibian & Christopher L. Bowlus. (2017) Primary sclerosing cholangitis: A review and update. Liver Research 1:4, pages 221-230.
Crossref
Crossref
John M. Vierling. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
489
522
.
Jennifer L. Horsley‐Silva, Eduardo A. Rodriguez, Diana L. Franco & Keith D. Lindor. (2017) An update on cancer risk and surveillance in primary sclerosing cholangitis. Liver International 37:8, pages 1103-1109.
Crossref
Crossref
Ken Liu, Ruoxi Wang, Viraj Kariyawasam, Mark Wells, Simone I. Strasser, Geoff McCaughan, Crispin Corte & Rupert W. Leong. (2017) Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort. Liver International 37:3, pages 442-448.
Crossref
Crossref
James H. Tabibian, Konstantinos N. Lazaridis & Nicholas F. LaRusso. 2017. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set
663
674.e5
.
Larissa Muething & James R. BurtonJr.Jr.. 2017. Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis
13
27
.
Hazem T. Hammad & Raj J. Shah. 2017. Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis
181
193
.
Juliana Rodrigues & David L. Diehl. (2016) Cholangiocarcinoma: Clinical manifestations and diagnosis. Techniques in Gastrointestinal Endoscopy 18:2, pages 75-82.
Crossref
Crossref
Trine Folseraas & Kirsten Muri Boberg. (2016) Cancer Risk and Surveillance in Primary Sclerosing Cholangitis. Clinics in Liver Disease 20:1, pages 79-98.
Crossref
Crossref
Sumera Rizvi, John E. Eaton & Gregory J. Gores. (2015) Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management. Clinical Gastroenterology and Hepatology 13:12, pages 2152-2165.
Crossref
Crossref
Keith D Lindor, Kris V Kowdley & Edwyn M Harrison. (2015) ACG Clinical Guideline: Primary Sclerosing Cholangitis. American Journal of Gastroenterology 110:5, pages 646-659.
Crossref
Crossref
Nandakumar Srinivasan & Richard Kozarek. 2015. Endoscopy in Inflammatory Bowel Disease. Endoscopy in Inflammatory Bowel Disease
309
322
.
Ijeoma A. Azodo, Rowan W. Parks & O. James Garden. 2014. Biliary Tract and Gallbladder Cancer. Biliary Tract and Gallbladder Cancer
1
31
.
Siddharth Singh & Jayant A. Talwalkar. (2013) Primary Sclerosing Cholangitis: Diagnosis, Prognosis, and Management. Clinical Gastroenterology and Hepatology 11:8, pages 898-907.
Crossref
Crossref
John E. Eaton & Jayant A. Talwalkar. (2013) Primary Sclerosing Cholangitis: Current and Future Management Strategies. Current Hepatitis Reports 12:1, pages 28-36.
Crossref
Crossref
Nataliya Razumilava & Gregory J. Gores. (2013) Classification, Diagnosis, and Management of Cholangiocarcinoma. Clinical Gastroenterology and Hepatology 11:1, pages 13-21.e1.
Crossref
Crossref
Konstantinos N. Lazaridis & Gregory J. Gores. 2013. Shackelford's Surgery of the Alimentary Tract. Shackelford's Surgery of the Alimentary Tract
1405
1416
.
G. L. Tyson, S. Keihanian & H. B. El-Serag. 2013. Hilar Cholangiocarcinoma. Hilar Cholangiocarcinoma
17
24
.
Mohamad H Imam, Keith D Lindor & Jayant A Talwalkar. (2012) Approaches to the design of clinical trials for primary sclerosing cholangitis. Clinical Investigation 2:8, pages 769-780.
Crossref
Crossref
Lena Sibulesky, Justin Nguyen & Tushar Patel. (2012) Preneoplastic conditions underlying bile duct cancer. Langenbeck's Archives of Surgery 397:6, pages 861-867.
Crossref
Crossref
Tarun Rustagi & Constantin A. Dasanu. (2011) Risk Factors for Gallbladder Cancer and Cholangiocarcinoma: Similarities, Differences and Updates. Journal of Gastrointestinal Cancer 43:2, pages 137-147.
Crossref
Crossref
Abby B. Siegel, Vladimir Sheynzon & Benjamin Samstein. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer
423
440
.
Douglas L. Nguyen, Nicholas F. LaRusso & Konstantinos N. Lazaridis. 2012. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
603
614.e3
.
Douglas L. Nguyen, Nicholas F. LaRusso & Konstantinos N. Lazaridis. 2011. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
475
489
.
Takumi Kawaguchi, Ryohei Kaji, Hiroyuki Horiuchi, Tomotake Shirono, Yusuke Ishida, Yoshinobu Okabe, Minoru Itou, Keiichi Mitsuyama, Jun Akiba, Osamu Nakashima, Hirohisa Yano, Masayoshi Kage, Masaru Harada, Shotaro Sakisaka & Michio Sata. (2011) Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis. Hepatology Research 41:12, pages 1253-1259.
Crossref
Crossref
David Goldberg, Benjamin French, Arwin Thomasson, K. Rajender Reddy & Scott D. Halpern. (2011) Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transplantation 17:11, pages 1355-1363.
Crossref
Crossref
Nataliya Razumilava, Gregory J. Gores & Keith D. Lindor. (2011) Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology 54:5, pages 1842-1852.
Crossref
Crossref
Gia L. Tyson & Hashem B. El-Serag. (2011) Risk factors for cholangiocarcinoma. Hepatology 54:1, pages 173-184.
Crossref
Crossref
E. L. Culver & R. W. Chapman. (2011) Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics 33:12, pages 1273-1291.
Crossref
Crossref
David Seth Goldberg, Benjamin French, Arwin Thomasson, K. Rajender Reddy & Scott D. Halpern. (2011) Current Trends in Living Donor Liver Transplantation for Primary Sclerosing Cholangitis. Transplantation 91:10, pages 1148-1152.
Crossref
Crossref
Mia Kumar, Xuelian Zhao & Xin Wei Wang. (2011) Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine?. Cell & Bioscience 1:1.
Crossref
Crossref
Armand Garioud, Philippe Seksik, Yves Chrétien, Christophe Corphechot, Raoul Poupon, Renée Eugénie Poupon & Olivier Chazouillères. (2010) Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. European Journal of Gastroenterology & Hepatology 22:7, pages 842-847.
Crossref
Crossref
Peter Neuhaus, Ulf P. Neumann & Daniel Seehofer. 2010. Malignant Liver Tumors. Malignant Liver Tumors
56
63
.
Adrian M. Di Bisceglie & Alex S. Befeler. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
1569
1592.e6
.
Rune Erichsen, Peter Jepsen, Hendrik Vilstrup, Anders Ekbom & Henrik Toft Sørensen. (2009) Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978–2003. European Journal of Epidemiology 24:9, pages 513-520.
Crossref
Crossref
Marian M.H. Claessen, Frank P. Vleggaar, Kristien M.A.J. Tytgat, Peter D. Siersema & Henk R. van Buuren. (2009) High lifetime risk of cancer in primary sclerosing cholangitis. Journal of Hepatology 50:1, pages 158-164.
Crossref
Crossref
M. Chaparro, J.A. Moreno-Monteagudo, L.C. Garca-Buey & R. Moreno-Otero. (2008) Enfermedades colest?sicas cr?nicas. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 10:12, pages 777-783.
Crossref
Crossref
T Kitiyakara & R W Chapman. (2008) Chemoprevention and screening in primary sclerosing cholangitis. Postgraduate Medical Journal 84:991, pages 228-237.
Crossref
Crossref
Karouk Said, Hans Glaumann & Annika Bergquist. (2008) Gallbladder disease in patients with primary sclerosing cholangitis. Journal of Hepatology 48:4, pages 598-605.
Crossref
Crossref
Patrick Yachimski & Daniel S. Pratt. (2008) Cholangiocarcinoma. Journal of Clinical Gastroenterology 42:2, pages 178-190.
Crossref
Crossref
Roger Chapman. 2008. Digestive Involvement in Systemic Autoimmune Diseases. Digestive Involvement in Systemic Autoimmune Diseases
169
188
.
Johan Fevery, Chris Verslype, Gillian Lai, Raymond Aerts & Werner Van Steenbergen. (2007) Incidence, Diagnosis, and Therapy of Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis. Digestive Diseases and Sciences 52:11, pages 3123-3135.
Crossref
Crossref
Tamir Ben-Menachem. (2007) Risk factors for cholangiocarcinoma. European Journal of Gastroenterology & Hepatology 19:8, pages 615-617.
Crossref
Crossref
Gregory T. Everson & Fernando E. Membreno. 2007. Textbook of Hepatology. Textbook of Hepatology
1984
1995
.
Sabine Kersting, Matthias Bruewer, Mike G. Laukoetter, Emile M. Rijcken, Rudolf Mennigen, Horst Buerger, Norbert Senninger & Christian F. Krieglstein. (2006) Intestinal cancer in patients with Crohn’s disease. International Journal of Colorectal Disease 22:4, pages 411-417.
Crossref
Crossref
A.J. SMALL, N.F. LARUSSO & K.N. LAZARIDIS. 2007. Surgery of the Liver, Biliary Tract and Pancreas. Surgery of the Liver, Biliary Tract and Pancreas
613
627
.
EDUARD JONAS, ERIK NASLUND, JACOB FREEDMAN, RAGNAR BEFRITS, LENNART BLOMQVIST, ANNA-KARIN SIOSTEEN, HANS JACOBSSON & ROLF HULTCRANTZ. (2006) Measurement of parenchymal function and bile duct flow in primary sclerosing cholangitis using dynamic 99mTc-HIDA SPECT. Journal of Gastroenterology and Hepatology 21:4, pages 674-681.
Crossref
Crossref
Nida S. Awadallah, Yang K. Chen, Cyrus Piraka, Mainor R. Antillon & Raj J. Shah. (2006) Is There a Role for Cholangioscopy in Patients with Primary Sclerosing Cholangitis?. The American Journal of Gastroenterology 101:2, pages 284-291.
Crossref
Crossref
Thomas Gerhardt. (2006) C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World Journal of Gastroenterology 12:34, pages 5495.
Crossref
Crossref
Erwin Kuntz. 2006. Hepatology Principles and Practice. Hepatology Principles and Practice
637
676
.
Andrea A. Gossard, Paul Angulo & Keith D. Lindor. (2005) Secondary Sclerosing Cholangitis: A Comparison to Primary Sclerosing Cholangitis. The American Journal of Gastroenterology 100:6, pages 1330-1333.
Crossref
Crossref
Lester J. Layfield & Harvey Cramer. (2005) Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: Report of two cases.. Diagnostic Cytopathology 32:2, pages 119-124.
Crossref
Crossref
Jayant A. Talwalkar & Keith D. Lindor. (2005) Primary Sclerosing Cholangitis. Inflammatory Bowel Diseases 11:1, pages 62-72.
Crossref
Crossref
Tal Zaks & Weijing Sun. 2005.
443
469
.
Roger Chapman & Sue Cullen. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology
435
451
.
Jens Koopmann, Paul J. Thuluvath, Marianna L. Zahurak, Troels Z. Kristiansen, Akhilesh Pandey, Richard Schulick, Pedram Argani, Manuel Hidalgo, Stefano Iacobelli, Michael Goggins & Anirban Maitra. (2004) Mac‐2‐binding protein is a diagnostic marker for biliary tract carcinoma. Cancer 101:7, pages 1609-1615.
Crossref
Crossref
Kelly Burak, Paul Angulo, Tousif M Pasha, Kathleen Egan, Jan Petz & Keith D Lindor. (2004) Incidence and Risk Factors for Cholangiocarcinoma in Primary Sclerosing Cholangitis. American Journal of Gastroenterology 99:3, pages 523-526.
Crossref
Crossref
Michael A. Heneghan, J. Elizabeth Tuttle-Newhall, Paul V. Suhocki, Andrew J. Muir, Michael Morse, Jeffrey D. Bornstein, Pamela B. Sylvestre, Bradley Collins, Paul C. Kuo & Don C. Rockey. (2003) De-Novo Cholangiocarcinoma in the Setting of Recurrent Primary Sclerosing Cholangitis Following Liver Transplant. American Journal of Transplantation 3:5, pages 634-638.
Crossref
Crossref
Albert M. RossIVIV, Sudha A. Anupindi & Ulysses J. Balis. (2003) Case 11-2003. New England Journal of Medicine 348:15, pages 1464-1476.
Crossref
Crossref
Weijing Sun & Daniel Haller. 2003.
509
534
.
Juan M Sarmiento & David M Nagorney. (2002) Hepatic resection in the treatment of perihilar cholangiocarcinoma. Surgical Oncology Clinics of North America 11:4, pages 893-908.
Crossref
Crossref
Andrew C. Henke, Chris S. Jensen & Michael B. Cohen. (2002) Cytologic Diagnosis of Adenocarcinoma in Biliary and Pancreatic Duct Brushings. Advances in Anatomic Pathology 9:5, pages 301-308.
Crossref
Crossref
Ann Knight, Johan Askling & Anders Ekbom. (2002) Cancer incidence in a population‐based cohort of patients with Wegener's granulomatosis. International Journal of Cancer 100:1, pages 82-85.
Crossref
Crossref
Jawad Ahmad & Adam Slivka. (2002) Hepatobiliary disease in inflammatory bowel disease. Gastroenterology Clinics of North America 31:1, pages 329-345.
Crossref
Crossref
Erwin Kuntz & Hans-Dieter KuntzErwin Kuntz & Hans-Dieter Kuntz. 2002. Hepatology. Hepatology
575
612
.
Morris Sherman & Ian Wanless. 2002. Cancer Precursors. Cancer Precursors
164
185
.
Annika Bergquist & Ulrika Broomé. (2001) Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology 15:4, pages 643-656.
Crossref
Crossref
Mushin Kaya, Piet C de Groen, Paul Angulo, David M Nagorney, Leonard L Gunderson, Gregory J Gores, Michael G Haddock & Keith D Lindor. (2001) Treatment of Cholangiocarcinoma Complicating Primary Sclerosing Cholangitis: The Mayo Clinic Experience. American Journal of Gastroenterology 96:4, pages 1164-1169.
Crossref
Crossref
W. Ray Kim, Terry M. Therneau, Russell H. Wiesner, John J. Poterucha, Joanne T. Benson, Michael Malinchoc, Nicholas F. Larusso, Keith D. Lindor & E. Rolland Dickson. (2000) A Revised Natural History Model for Primary Sclerosing Cholangitis. Mayo Clinic Proceedings 75:7, pages 688-694.
Crossref
Crossref
Shigeki Yokomuro, Hirokazu Tsuji, John G. Lunz, Toshiki Sakamoto, Tsukasa Ezure, Noriko Murase & Anthony J. Demetris. (2000) Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factorβ1, and activin a: Comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 32:1, pages 26-35.
Crossref
Crossref
W. RAY KIM, TERRY M. THERNEAU, RUSSELL H. WIESNER, JOHN J. POTERUCHA, JOANNE T. BENSON, MICHAEL MALINCHOC, NICHOLAS F. LARUSSO, KEITH D. LINDOR & E. ROLLAND DICKSON. (2000) A Revised Natural History Model for Primary Sclerosing Cholangitis. Mayo Clinic Proceedings 75:7, pages 688-694.
Crossref
Crossref
Piet C. de Groen. (2000) Cholangiocarcinoma in primary sclerosing cholangitis: Who is at risk and how do we screen?. Hepatology 31:1, pages 247-248.
Crossref
Crossref
Naga Chalasani, Arthur Baluyut, Ayaaz Ismail, Atif Zaman, Gagan Sood, Reem Ghalib, T. M. McCashland, K. Rajender Reddy, Xaralambos Zervos, Mann A. Anbari & Helena Hoen. (2000) Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology 31:1, pages 7-11.
Crossref
Crossref
Piet C. de Groen, Gregory J. Gores, Nicholas F. LaRusso, Leonard L. Gunderson & David M. Nagorney. (1999) Biliary Tract Cancers. New England Journal of Medicine 341:18, pages 1368-1378.
Crossref
Crossref
Steven A. Ahrendt, Claus F. Eisenberger, Lin Yip, Asif Rashid, John T. Chow, Henry A. Pitt & David Sidransky. (1999) Chromosome 9p21 Loss and p16 Inactivation in Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma. Journal of Surgical Research 84:1, pages 88-93.
Crossref
Crossref
Steven A. Ahrendt. (1999) Biliary tract surgery. Current Gastroenterology Reports 1:2, pages 107-115.
Crossref
Crossref
Ernesto P. Molmenti, J. Wallis Marsh, Igor Dvorchik, James H. OliverIIIIII, Juan Madariaga & Shunzaburo Iwatsuki. (1999) HEPATOBILIARY MALIGNANCIES. Surgical Clinics of North America 79:1, pages 43-57.
Crossref
Crossref
P.M. Harrison. (1999) Prevention of bile duct cancer in primary sclerosing cholangitis. Annals of Oncology 10, pages S208-S211.
Crossref
Crossref
C. Caldas. (1999) Biliopancreatic malignancy: Screening the at risk patient with molecular markers. Annals of Oncology 10, pages S153-S156.
Crossref
Crossref
Marco Bacosi, Marco Delle Monache, Francesca Russo & Giovanni L. Ricci. 1999. Advances in Abdominal Surgery. Advances in Abdominal Surgery
197
221
.
Anders Ekbom. (1998) Risk Factors and Distinguishing Features of Cancer in IBD. Inflammatory Bowel Diseases 4:3, pages 235-243.
Crossref
Crossref